Setyono-Han B - Search Results

1

Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: preclinical and clinical studies.

Klijn JG, Setyono-Han B, Bakker GH, van der Burg ME, Bontenbal M, Peters HA, Sieuwerts AM, Berns PM, Foekens JA. Klijn JG, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1089-95. doi: 10.1016/0960-0760(90)90471-v. J Steroid Biochem Mol Biol. 1990. PMID: 1981013 Review.

2

Treatment of breast cancer with different antiprogestins: preclinical and clinical studies.

Bakker GH, Setyono-Han B, Portengen H, De Jong FH, Foekens JA, Klijn JG. Bakker GH, et al. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):789-94. doi: 10.1016/0960-0760(90)90421-g. J Steroid Biochem Mol Biol. 1990. PMID: 2285592

3

Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.

Bakker GH, Setyono-Han B, Portengen H, De Jong FH, Foekens JA, Klijn JG. Bakker GH, et al. Endocrinology. 1989 Sep;125(3):1593-8. doi: 10.1210/endo-125-3-1593. Endocrinology. 1989. PMID: 2527151

4

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer.

Klijn JG, Setyono-Han B, Foekens JA. Klijn JG, et al. Among authors: setyono han b. Steroids. 2000 Oct-Nov;65(10-11):825-30. doi: 10.1016/s0039-128x(00)00195-1. Steroids. 2000. PMID: 11108894 Review.

5

Pre-clinical and clinical treatment of breast cancer with antiprogestins.

Klijn JG, Setyono-Han B, Sander HJ, Lamberts SW, de Jong FH, Deckers GH, Foekens JA. Klijn JG, et al. Hum Reprod. 1994 Jun;9 Suppl 1:181-9. doi: 10.1093/humrep/9.suppl_1.181. Hum Reprod. 1994. PMID: 7962463 Review.

6

Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1.

Setyono-Han B, Stürzebecher J, Schmalix WA, Muehlenweg B, Sieuwerts AM, Timmermans M, Magdolen V, Schmitt M, Klijn JG, Foekens JA. Setyono-Han B, et al. Thromb Haemost. 2005 Apr;93(4):779-86. doi: 10.1160/TH04-11-0712. Thromb Haemost. 2005. PMID: 15841327

7

The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumors.

Bakker GH, Setyono-Han B, Foekens JA, Portengen H, van Putten WL, de Jong FH, Lamberts SW, Reubi JC, Klijn JG. Bakker GH, et al. Breast Cancer Res Treat. 1990 Nov;17(1):23-32. doi: 10.1007/BF01812681. Breast Cancer Res Treat. 1990. PMID: 1965705

8

Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.

Bakker GH, Setyono-Han B, Henkelman MS, de Jong FH, Lamberts SW, van der Schoot P, Klijn JG. Bakker GH, et al. Cancer Treat Rep. 1987 Nov;71(11):1021-7. Cancer Treat Rep. 1987. PMID: 3119199

9

Novel endocrine therapies in breast cancer.

Klijn JG, Setyono-Han B, Bontenbal M, Seynaeve C, Foekens J. Klijn JG, et al. Among authors: setyono han b. Acta Oncol. 1996;35 Suppl 5:30-7. doi: 10.3109/02841869609083965. Acta Oncol. 1996. PMID: 9142962 Review.

10

Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells.

Sieuwerts AM, Klijn JG, Henzen-Logmand SC, Bouwman I, Van Roozendaal KE, Peters HA, Setyono-Han B, Foekens JA. Sieuwerts AM, et al. Among authors: setyono han b. Int J Cancer. 1998 Jun 10;76(6):829-35. doi: 10.1002/(sici)1097-0215(19980610)76:6<829::aid-ijc11>3.0.co;2-y. Int J Cancer. 1998. PMID: 9626349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters